These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2557409)

  • 1. Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3',5'-monophosphate-selective phosphodiesterase inhibitor.
    McMahon EG; Palomo MA; Mehta P; Olins GM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1000-5. PubMed ID: 2557409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
    Wilkins MR; Settle SL; Needleman P
    J Clin Invest; 1990 Apr; 85(4):1274-9. PubMed ID: 2156897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor.
    Trapani AJ; Smits GJ; McGraw DE; McMahon EG; Blaine EH
    J Pharmacol Exp Ther; 1991 Jul; 258(1):269-74. PubMed ID: 1649294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulating effects of atrial natriuretic peptide on vascular permeability and blood pressure by inhibition of cyclic phosphodiesterase GMP in the rat].
    Valentin JP; Humphreys MH
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1219-22. PubMed ID: 1336359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
    Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
    Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
    J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.
    Dundore RL; Clas DM; Wheeler LT; Habeeb PG; Bode DC; Buchholz RA; Silver PJ; Pagani ED
    Eur J Pharmacol; 1993 Nov; 249(3):293-7. PubMed ID: 8287916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP; Safai M; Gardner DG; Humphreys MH
    Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
    Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
    Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
    Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
    J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
    Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
    Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure.
    Wilkins MR; Settle SL; Stockmann PT; Needleman P
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6465-9. PubMed ID: 2166956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
    Blaine EH; Seymour AA; Marsh EA; Napier MA
    Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
    Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
    J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
    Kodama K; Adachi H
    J Pharmacol Exp Ther; 1999 Aug; 290(2):748-52. PubMed ID: 10411587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
    Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
    Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.